Paolo Emanuele P E Levi-Setti1, Andrea Borini2, Pasquale Patrizio3, Simone Bolli4, Vincenzo Vigiliano4, Roberto De Luca4, Giulia Scaravelli4. 1. Department of Gynaecology, Division of Gynaecology and Reproductive Medicine, Humanitas Fertility Center, Humanitas Research Hospital, Rozzano, Milan, Italy. paolo.levi_setti@humanitas.it. 2. Tecnobios Procreazione, Bologna, Italy. 3. Department of Obstetrics, Gynaecology and Reproductive Sciences, Yale University, School of Medicine, New Haven, CT, USA. 4. ART Italian National Register, National Centre for Epidemiology, Surveillance and Health Promotion, National Health Institute, Rome, Italy.
Abstract
PURPOSE: This study is a retrospective collection of aggregated data from all the Italian ART centers reporting to the Italian National Register from cycles started between January 2005 and December 2013. METHODS: Data from both slow freezing (SF) and vitrification (V) were assessed for the period 2007-2013, while during the years 2005-2006 cryopreservation was exclusively performed by SF. RESULTS: In the study period, a total of 2,526,024 oocytes were retrieved (from 378,543 retrievals), of which 1,346,061 (53.3 %) were inseminated in fresh cycles and 214,481 (8.5 %) were cryopreserved. Cryopreserved oocytes were used in 24,173 cycles yielding 19,453 transfer cycles (80.5 % of the thawing/warming cycles) and 3043 clinical pregnancies (15.6 % per transfer). A significant difference in implantation (8.7 vs 12.9 % OR 1.30 CI 1.20-1.40) and pregnancy rates per transfer (12.2 vs 14.9 % OR 1.34 CI 1.23-1.46) was found between SF and V. Complete outcome data was available for 2708 pregnancies (89.8 %), leading to 1882 deliveries and 2152 live births. Neonatal major congenital anomalies were 0.9 % (20/2152). CONCLUSIONS: A wide variation in pregnancy rates were found among different centers and lower rates were reported in donor cycles and in centers with more experience.
PURPOSE: This study is a retrospective collection of aggregated data from all the Italian ART centers reporting to the Italian National Register from cycles started between January 2005 and December 2013. METHODS: Data from both slow freezing (SF) and vitrification (V) were assessed for the period 2007-2013, while during the years 2005-2006 cryopreservation was exclusively performed by SF. RESULTS: In the study period, a total of 2,526,024 oocytes were retrieved (from 378,543 retrievals), of which 1,346,061 (53.3 %) were inseminated in fresh cycles and 214,481 (8.5 %) were cryopreserved. Cryopreserved oocytes were used in 24,173 cycles yielding 19,453 transfer cycles (80.5 % of the thawing/warming cycles) and 3043 clinical pregnancies (15.6 % per transfer). A significant difference in implantation (8.7 vs 12.9 % OR 1.30 CI 1.20-1.40) and pregnancy rates per transfer (12.2 vs 14.9 % OR 1.34 CI 1.23-1.46) was found between SF and V. Complete outcome data was available for 2708 pregnancies (89.8 %), leading to 1882 deliveries and 2152 live births. Neonatal major congenital anomalies were 0.9 % (20/2152). CONCLUSIONS: A wide variation in pregnancy rates were found among different centers and lower rates were reported in donor cycles and in centers with more experience.
Entities:
Keywords:
ART registry; Congenital anomalies; Cumulative ART pregnancy rate; Oocyte freezing; Safety in ART
Authors: Laura Rienzi; Clarisa Gracia; Roberta Maggiulli; Andrew R LaBarbera; Daniel J Kaser; Filippo M Ubaldi; Sheryl Vanderpoel; Catherine Racowsky Journal: Hum Reprod Update Date: 2017-03-01 Impact factor: 15.610
Authors: G Scaravelli; P E Levi-Setti; C Livi; G La Sala; F M Ubaldi; E Greco; M E Coccia; A Borini; A Revelli; G Ricci; V Vigiliano; R De Luca; S Bolli; L Rienzi Journal: J Assist Reprod Genet Date: 2019-08-28 Impact factor: 3.412
Authors: Jessica Cremonese; Marianna Marcon; Laura Oppi; Giulia Paletti; Vincenzo Romolo; Pamela Tozzo; Luciana Caenazzo Journal: Int J Environ Res Public Health Date: 2022-02-18 Impact factor: 3.390